NumFin

China Medicine Corporation

符号: CHME

PNK

0.028

USD

今天的市场价格

  • 0.0009

    市盈率

  • -0.0001

    PEG比率

  • 79.67M

    MRK市值

  • 0.00%

    DIV收益率

China Medicine Corporation (CHME) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 China Medicine Corporation (CHME). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 China Medicine Corporation 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM200920082007200620052004

balance-sheet.row.cash-and-short-term-investments

00.52.85.8
0.4
0
0.2

balance-sheet.row.short-term-investments

0000
0
0
0

balance-sheet.row.net-receivables

022.319.813.6
7
0
1.4

balance-sheet.row.inventory

02.74.73.9
1.9
0
0.8

balance-sheet.row.other-current-assets

00.56.36.1
4.1
0
0.5

balance-sheet.row.total-current-assets

030.333.729.4
13.4
0
2.8

balance-sheet.row.property-plant-equipment-net

0123.81.4
1.2
0
0.3

balance-sheet.row.goodwill

0000
0
0
0

balance-sheet.row.intangible-assets

016.71.21.2
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

016.71.21.2
0
0
0.3

balance-sheet.row.long-term-investments

07.900
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0

balance-sheet.row.other-non-current-assets

0060.7
0
0
0

balance-sheet.row.total-non-current-assets

036.6113.2
1.2
0
0.5

balance-sheet.row.other-assets

0000
0
0
0

balance-sheet.row.total-assets

066.844.732.6
14.6
0
3.4

balance-sheet.row.account-payables

01.30.10
0.2
0
0.5

balance-sheet.row.short-term-debt

09.500
0
0
0

balance-sheet.row.tax-payables

02.10.80
0
0
0.1

balance-sheet.row.long-term-debt-total

0000
0
0
0

Deferred Revenue Non Current

0000
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-

balance-sheet.row.other-current-liab

00.510.9
0.4
0
0.8

balance-sheet.row.total-non-current-liabilities

06.900
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0

balance-sheet.row.total-liab

021.31.10.9
0.6
0
1.3

balance-sheet.row.preferred-stock

0000
0
0
0

balance-sheet.row.common-stock

0000
0
0
0

balance-sheet.row.retained-earnings

022.922.114
8
0
1.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

04.44.44.3
0.8
0
0

balance-sheet.row.other-total-stockholders-equity

017.716.212.6
4.4
0
0.8

balance-sheet.row.total-stockholders-equity

04542.830.9
13.1
0
2.1

balance-sheet.row.total-liabilities-and-stockholders-equity

066.844.732.6
14.6
0
3.4

balance-sheet.row.minority-interest

00.50.80.9
0.9
0
0

balance-sheet.row.total-equity

045.543.631.8
14
0
2.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-

Total Investments

07.900
0
0
0

balance-sheet.row.total-debt

09.500
0
0
0

balance-sheet.row.net-debt

09-2.8-5.8
-0.4
0
-0.2

现金流量表

在 China Medicine Corporation 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM200920082007200620052004

cash-flows.row.net-income

01.49.16.9
4.8
0
2.9

cash-flows.row.depreciation-and-amortization

010.40.8
0.2
0
0.1

cash-flows.row.deferred-income-tax

0000
0
0
-0.1

cash-flows.row.stock-based-compensation

00.10.10
0
0
0

cash-flows.row.change-in-working-capital

07.1-5.4-10.1
-8
0
-0.5

cash-flows.row.account-receivables

0-2.3-4.80
0
0
0

cash-flows.row.inventory

03.4-0.5-1.8
-0.5
0
-0.6

cash-flows.row.account-payables

00.600
0
0
0

cash-flows.row.other-working-capital

05.4-0.1-8.2
-7.5
0
0.1

cash-flows.row.other-non-cash-items

07.3-0.10.1
0.8
0
0.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-3.7-2.7-0.4
-0.8
0
0

cash-flows.row.acquisitions-net

0-800
0
0
0

cash-flows.row.purchases-of-investments

00-5.20
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0

cash-flows.row.other-investing-activites

0-1.900
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-13.5-7.9-0.4
-0.8
0
0

cash-flows.row.debt-repayment

0-10.600
0
0
-0.1

cash-flows.row.common-stock-issued

0007.8
3.8
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0

cash-flows.row.dividends-paid

0000
0
0
-2.3

cash-flows.row.other-financing-activites

04.90.40
-0.3
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-5.70.47.8
3.5
0
-2.4

cash-flows.row.effect-of-forex-changes-on-cash

000.30.3
-0.2
0
0

cash-flows.row.net-change-in-cash

0-2.3-35.4
0.3
0
0.1

cash-flows.row.cash-at-end-of-period

00.52.85.8
0.4
0
0.2

cash-flows.row.cash-at-beginning-of-period

02.85.80.4
0.1
0
0.1

cash-flows.row.operating-cash-flow

0174.2-2.3
-2.2
0
2.5

cash-flows.row.capital-expenditure

0-3.7-2.7-0.4
-0.8
0
0

cash-flows.row.free-cash-flow

013.31.5-2.7
-3
0
2.5

利润表行

China Medicine Corporation 的收入与上期相比变化了 NaN%。据报告, CHME 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM200920082007200620052004

income-statement-row.row.total-revenue

064.853.642.1
24
0
10.4

income-statement-row.row.cost-of-revenue

045.838.129.7
15
0
7.2

income-statement-row.row.gross-profit

01915.612.4
9
0
3.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0

income-statement-row.row.research-development

0---
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0

income-statement-row.row.operating-expenses

06.74.64
2.8
0
0.8

income-statement-row.row.cost-and-expenses

052.542.733.7
17.8
0
8

income-statement-row.row.interest-income

0000
0
0
0

income-statement-row.row.interest-expense

0000
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-

income-statement-row.row.total-other-income-expensenet

0-7.30.10
-1.1
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0

income-statement-row.row.total-operating-expenses

0-7.30.10
-1.1
0
0

income-statement-row.row.interest-expense

0000
0
0
0

income-statement-row.row.depreciation-and-amortization

010.40.8
0.2
0
0.1

income-statement-row.row.ebitda-caps

0---
-
-
-

income-statement-row.row.operating-income

012.310.98.4
6.2
0
2.4

income-statement-row.row.income-before-tax

05118.4
6
0
2.4

income-statement-row.row.income-tax-expense

03.521.6
1.2
0
-0.5

income-statement-row.row.net-income

01.79.16.9
4.8
0
2.9
类似股票
您可能还对以下内容感兴趣：
MEPDF
MediPal Holdings Corporation.
16.43 USD
PNK
EXHI
Exlites Holdings International, Inc..
0.07 USD
PNK
601607.SS
Shanghai Pharmaceuticals Holding Co., Ltd.
18.21 CNY
SHH
0673.HK
China Health Group Limited.
1.08 HKD
HKSE
MLTO
MEDirect Latino, Inc..
0.000001 USD
PNK
ABC
AmerisourceBergen Corporation.
179.98 USD
NYSE
MED.MC
Medcomtech, S.A..
0.69 EUR
EURONEXT
3183.T
WIN-Partners Co., Ltd..
1242 JPY
JPX
GEG
Great Elm Group, Inc..
1.97 USD
NASDAQ

常见问题

什么是 China Medicine Corporation (CHME) 总资产是多少？

China Medicine Corporation (CHME) 总资产为 66844482.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.293.

什么是公司自由现金流？

自由现金流为 0.870.

什么是企业净利润率？

净利润率为 0.027.

企业总收入是多少？

总收入为 0.189.

什么是 China Medicine Corporation (CHME) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 1717677.000.

公司总债务是多少？

债务总额为 9506160.000.

营业费用是多少？

运营支出为 6718099.000.

公司现金是多少？

企业现金为 0.000.